Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 17,000 PLX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 17,000 | n/a |
| Sep 4, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 7,500 | n/a |
| Feb 7, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 65,000 | n/a |
| Oct 3, 2023 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 61,676 | n/a |
| Jan 30, 2023 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 50,000 | n/a |
| Sep 9, 2022 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 50,000 | n/a |
| Jan 25, 2022 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 50,000 | n/a |
| Mar 29, 2021 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 50,000 | n/a |
| Mar 16, 2020 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 300,000 | n/a |
| Jan 22, 2020 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 40,000 | n/a |